Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This systematic review and meta-analysis reported that deuruxolitinib is effective for hair regrowth and improving patient-reported outcomes in individuals with moderate to severe alopecia areata, but observed manageable treatment-emergent adverse events such as elevated creatinine kinase levels and headaches, particularly with higher doses.

This event summary describes a live-surgery workshop hosted by Matt Leavitt and his team with new co-sponsorship by the International Society of Hair Restoration but provides no research findings.

In this case report, a 26-year-old man with alopecia universalis, resistant to multiple standard treatments, achieved complete and sustained hair regrowth with ruxolitinib, highlighting its potential as a promising option for patients with refractory AU.

This announcement details the World Association of Hair Restoration Surgeons' upcoming live workshop in Orlando and does not provide any new research findings.

This abstract contains author information and a disclosure regarding the Mohebi Inserter for hair transplantation but provides no new clinical research findings.

In this study, researchers describe the FUE method of hair micrografting, which involves extracting and implanting follicular units using advanced tools, leading to more natural results, quicker recovery, and less damage to donor sites.

This study found that the hydrophilic PTK-UR foam with EG7 repeats significantly improved wound healing in porcine skin wounds compared to other scaffolds, suggesting potential for synthetic biomaterial applications.

This case study reports a new LAMB3 mutation linked to junctional epidermolysis bullosa with severe urinary tract stenosis, outlining treatment challenges and expanding knowledge of EB-related urological complications.

In this study, the researchers developed an optimal emulgel formulation for treating androgenic alopecia, determining that a base with 0.3% Carbomer Ultraz 10, 0.1% potassium sorbate, and 0.2% triethanolamine offered the best properties for drug release, application compliance, safety, and stability.

This article discusses the advancements in follicular unit transplantation for hair restoration and reports no clinical results; it emphasizes improved aesthetic outcomes using updated techniques.

In this study, disruptions in phospholipase A2 activity in Arabidopsis thaliana significantly impaired the plasma membrane localization of PIN proteins, affecting auxin transport and root development.

In this report, a clinical case demonstrated complete hair regrowth in a 29-year-old male with recurrent alopecia areata following five months of Ayurvedic treatments, including Virechan therapy, Shamana Chikitsa, and leech therapy, with no adverse effects reported.

This paper introduces the Follicular Unit Extraction procedure and its accompanying FOX Test, finding that 60% of tested patients were suitable candidates for this minimally invasive hair transplantation method.

This case study suggests that homeopathic treatment with Pulsatilla may have contributed to improved menstrual regularity and ultrasonography results in a 22-year-old woman with PCOS.

This study developed a method using ultra-performance liquid chromatography and mass spectrometry to detect illegal substances in hair loss prevention cosmetics, revealing that some products contained high levels of minoxidil and finasteride, posing safety risks.

In this study, researchers identified three root hair-specific peroxidases that may control cell wall properties during root hair cell expansion, affecting growth, enzyme activity, and cell wall structure.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

This study found that elagolix treatment did not normalize the ovulatory cycle in patients with polycystic ovarian syndrome.

GLABRA2 represses root hair formation by inhibiting a specific gene.

This study found that a new deoxycholic acid derivative may offer a similar prostatoprotective effect to finasteride with lower toxicity in rat models.